
Life360 delivers powerful subscription and advertising growth, expanding margins and accelerating global penetration. Strong MAU momentum, rising Paying Circles, and a breakout technical setup reinforce the company’s position as a high‑growth digital safety leader.
.webp&w=828&q=75)
BlinkLab (ASX: BB1) is advancing its autism and ADHD assessment technology through clinical studies, FDA validation work, and research partnerships. Recent technical strength reflects growing investor interest, though regulatory and commercial risks remain.

Pro Medicus (ASX: PME) delivers record revenue growth, expanding margins, and accelerating AI‑driven innovation, reinforcing its global leadership in enterprise imaging and cloud‑based diagnostics.
.webp&w=828&q=75)
Bannerman Energy (ASX: BMN) advances Etango uranium project with CNNC financing, strong early works execution, and rising uranium prices, positioning as a leveraged mid-cap growth play in a buoyant nuclear fuel market.

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.

IGO (ASX: IGO) delivers strong FY26 results with disciplined execution, expanding margins at Greenbushes and Nova, and strategic portfolio optimisation aligned with global energy transition.